Tachycardia Clinical Trials in Nashville, Tennessee
13 recruitingNashville, Tennessee
Showing 1–13 of 13 trials
Recruiting
Not Applicable
Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)
Ventricular Tachycardia (VT)
Medtronic Cardiac Ablation Solutions60 enrolled6 locationsNCT06703489
Recruiting
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Heart FailureArrhythmiaBradycardia+1 more
Medtronic20,000 enrolled320 locationsNCT00271180
Recruiting
Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies
Atrial FibrillationVentricular TachycardiaPremature Ventricular Contraction
Vanderbilt University Medical Center200 enrolled1 locationNCT06575881
Recruiting
Not Applicable
Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)
Tachycardia, Ventricular
Varian, a Siemens Healthineers Company380 enrolled11 locationsNCT05765175
Recruiting
ATrial Tachycardia PAcing Therapy in Congenital Heart
Atrial ArrhythmiaAtrial TachycardiaCongenital Heart Disease+1 more
Ian Law300 enrolled15 locationsNCT03209583
Recruiting
Phase 2
Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)
Postural Orthostatic Tachycardia Syndrome (POTS)
Regeneron Pharmaceuticals81 enrolled18 locationsNCT06593600
Recruiting
Defining the Risk of Ventricular Tachycardia in Genetic Forms of Early-onset Atrial Fibrillation
Atrial FibrillationVentricular Tachycardia
Vanderbilt University Medical Center200 enrolled1 locationNCT06647459
Recruiting
Phase 2
Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS
SARS-CoV-2 infectionPost-Acute COVID-19 SyndromeLong Covid19+1 more
Vanderbilt University Medical Center50 enrolled1 locationNCT07189936
Recruiting
Not Applicable
Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome
SARS-CoV-2 infectionPost-Acute COVID-19 SyndromeLong COVID+1 more
Vanderbilt University Medical Center60 enrolled1 locationNCT05421208
Recruiting
Phase 2
Restoring Iron Deficiency in POTS
POTS - Postural Orthostatic Tachycardia Syndrome
Vanderbilt University Medical Center12 enrolled1 locationNCT07197905
Recruiting
Not Applicable
Long COVID Immune Profiling
Autonomic DysfunctionLong COVIDPOTS - Postural Orthostatic Tachycardia Syndrome
Vanderbilt University Medical Center150 enrolled1 locationNCT06027255
Recruiting
Phase 2
Splanchnic Venous Capacitance in Postural Tachycardia Syndrome
Postural Tachycardia Syndrome (POTS)
Vanderbilt University Medical Center50 enrolled1 locationNCT05375968
Recruiting
Not Applicable
Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT
Refractory Ventricular Tachycardia
Thermedical, Inc.130 enrolled7 locationsNCT05337241